Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
YSBHKSE:09885 +6.77%74 Market Cap is HK$2,449 Mil as of Aug. 23, 2026. GuruFocus rates HKSE:09885 with a GF Score™ of 74/100 and a GF Value™ of HK$7.39 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 693 Healthcare Providers & Services companies, YSB ranks better than 65.37% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). YSB's share price for the quarter that ended in Jun. 2026 was HK$4.31. YSB's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 690 Mil. Therefore, YSB's market cap for the quarter that ended in Jun. 2026 was HK$2,974 Mil.
YSB's quarterly market cap
declined
from Jun. 2025 (HK$6,419 Mil) to Dec. 2025 (HK$3,655 Mil) and
declined
from Dec. 2025 (HK$3,655 Mil) to Jun. 2026 (HK$2,974 Mil).
YSB's annual market cap
declined
from Dec. 2023 (HK$5,276 Mil) to Dec. 2024 (HK$3,828 Mil) and
declined
from Dec. 2024 (HK$3,828 Mil) to Dec. 2025 (HK$3,655 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. YSB's Enterprise Value for Today is HK$686 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
YSB Market Cap Related Terms
YSB Market Cap Historical Data
* Premium members only.
The historical data trend for YSB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, YSB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
YSB Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, YSB's Market Cap distribution charts can be found below:
* The bar in red indicates where YSB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
YSB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
YSB (HKSE:09885) has a Market Cap of HK$2,449 Mil as of Aug. 23, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on YSB and its competitors. According to the industry distribution chart, YSB ranks #240 out of 693 companies in the Healthcare Providers & Services industry, placing it in the top 34.6%.
Is YSB's Market Cap too high?
YSB's current Market Cap is HK$2,449 Mil. Based on the distribution chart, YSB ranks #240 out of 693 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, YSB has a GF Score™ of 74/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does YSB's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, YSB ranks #240 out of 693 companies for Market Cap. This puts YSB in the upper half of its industry. The industry median Market Cap is 106.38. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 106.38, based on 693 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on YSB and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 106.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. YSB's current Market Cap is HK$2,449 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is YSB stock overvalued right now?
Based on GuruFocus' analysis, YSB (HKSE:09885) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$7.39, compared to a current price of HK$3.55 — trading 52% below its estimated fair value. The current Market Cap is HK$2,449 Mil. YSB's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For YSB (HKSE:09885), the current Market Cap is HK$2,449 Mil as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is YSB (HKSE:09885) Overvalued in 2026?
Based on GuruFocus' analysis, YSB stock appears to be undervalued.
The current stock price of HK$3.55 is trading 52% below its estimated GF Value™ of HK$7.39.
GuruFocus considers YSB to be Significantly Undervalued.
Key valuation signals for HKSE:09885:
Market Cap: HK$2,449 Mil
GF Value™: HK$7.39 vs. price of HK$3.55 (52% below fair value)
No single metric tells the full story. See the HKSE:09885 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
YSB Inc is a digital pharmaceutical platform serving businesses outside of hospitals in China. The group is engaged in the wholesale and retail of pharmaceutical and healthcare products through offline channels, retail shops, and its online platform. It also operates an online marketplace that enables pharmaceutical distributors and vendors to sell pharmaceutical and healthcare products through the Group's platform. In addition, the Group provides SaaS solutions to downstream pharmacies and primary healthcare institutions to streamline inventory and patient management, and offers system technologies and operational support services through smart healthcare systems, integrated point-of-care testing and monitoring devices, digital management systems, and smart AI doctor-aid systems.
74GF Score
Get the complete analysis for HKSE:09885
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09885 has been successfully added to your 
